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Abstract: Atrazine is an herbicide commonly used on crops to prevent broadleaf weeds. Atrazine is
an endocrine-disrupting chemical mainly targeting the neuroendocrine system and associated axes,
especially as a reproductive toxicant through attenuation of the luteinizing hormone (LH). Current
regulatory levels for chronic exposure are based on no observed adverse effect levels (NOAELs) of
these LH alterations in rodent studies. Atrazine has also been studied for its effects on the central
nervous system and neurotransmission. The European Union (EU) recognized the health risks of
atrazine exposure as a public health concern with no way to contain contamination of drinking water.
As such, the EU banned atrazine use in 2003. The United States recently reapproved atrazine’s use
in the fall of 2020. Research has shown that there is a wide array of adverse health effects that are
seen across multiple models, exposure times, and exposure periods leading to dysfunction in many
different systems in the body with most pointing to a neuroendocrine target of toxicity. There is
evidence of crosstalk between systems that can be affected by atrazine exposure, causing widespread
dysfunction and leading to changes in behavior even with no direct link to the hypothalamus. The
hypothetical mechanism of toxicity of atrazine endocrine disruption and neurotoxicity can therefore
be described as a web of pathways that are influenced through changes occurring in each and their
multiple feedback loops with further research needed to refine NOAELs for neurotoxic outcomes.
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1. Introduction
The herbicide atrazine (6-chloro-N-ethyl-N-(1-methylethyl)-1,3,5-triazine-2,4-diamine) is
one of a family of chemicals known as triazines and is in the top two herbicides used in the
United States [1,2]. Triazines are historical for being endocrine-disrupting chemicals and research
has supported this hypothesis in regard to atrazine specifically. Atrazine is used on crops in the
United States and other global regions for the control of both broadleaf and grassy weeds [1].
Any population living in close proximity to where atrazine is applied, such as in the United
States Midwest, is particularly vulnerable to atrazine exposure due to the large land masses
used to farm crops, such as corn, that are treated with the chemical [3]. The most common route
of environmental exposure to this toxicant is through ingestion of contaminated drinking water,
while inhalation and dermal absorption can occur in occupational settings during the production
of atrazine as well as the application to crops [1,3,4]. The European Union (EU) recognized the
potential harm that atrazine has on public health regarding its endocrine-disrupting nature
and involvement in adverse reproductive and development outcomes. Therefore, in 2003,
the EU reevaluated a potential ban on the use of atrazine. The herbicide was not approved
for use to prevent drinking water contamination, because of the difficulty in containing the
chemical when in use, often exceeding the concentration limit set [5]. Recently, in the fall of
2020, the United States Environmental Protection Agency (US EPA) reapproved atrazine for
use as well as eliminated some of the requirements of monitoring atrazine in drinking water
by doing away with the Atrazine Monitoring Program (AMP). The agency states that the
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concentrations that are regularly measured are routinely low with the highest recorded atrazine
concentration in drinking water being much lower than the limit set for triazines. However, the
Atrazine Ecological Exposure Monitoring Program (AEEMP) will still be continued because
concentrations in the environment pose ecological risk [6]. The US EPA maximum contaminant
level (MCL) for atrazine in drinking water is 3 parts per billion (ppb, µg/L), but in contrast to
the above statements, others report it is likely that during peak crop seasons, when use is most
abundant, this regulatory limit can be exceeded both in ground and surface drinking water
sources [2,3]. In addition, the World Health Organization’s (WHO) current regulatory limit for
atrazine in drinking water is much higher, set at 100 ppb.
Atrazine has been extensively studied for years in regard to its adverse developmental and reproductive outcomes in many different models, in vivo and in vitro, with
the current no observed adverse effect level (NOAEL) at 10 mg/kg/day and the LOAEL
at 70 mg/kg/day for acute dietary exposure and the NOAEL at 1.8 mg/kg/day and
the LOAEL at 3.65 mg/kg/day for chronic dietary exposure based on neuroendocrine
impacts [7–11]. Many epidemiological studies have also found correlations and associations between atrazine exposure and outcomes such as preterm delivery and small-forgestational-age, birth defects, and other adverse birth outcomes. The region of focus for
many of these studies typically tends to be populations residing in the US Midwest where
drinking water contamination is high and proximity to crop fields where atrazine is used
is more prevalent [1,3,12–16]. Other epidemiological studies have shown an association
between atrazine exposure at concentrations below the MCL set by the US EPA with the
alteration of hormones involved in the menstrual cycle as well as reduced semen quality
in areas proximal to pesticide usage [17,18]. Recent research is beginning to look at other
areas of the brain that may be affected and how the dysregulation of different systems
caused by atrazine are interconnected with the reproductive outcomes seen.
Broadly, atrazine exposure is known to affect the neuroendocrine system and associated endocrine axes, specifically the hypothalamus-pituitary-gonadal (HPG) axis. Studies
have shown adverse effects on pubertal development of rats, mammary gland development in prenatally exposed offspring, changes in luteinizing hormone (LH) surge and
gonadotropin-releasing hormone (GnRH) release in female rats, and delayed vaginal
opening associated with delayed puberty [8,19–23]. Other research on male organismal
models have shown that the male offspring of dams treated with atrazine during pregnancy had drastically reduced levels of testosterone, while other studies showed that
maternal toxicity did not affect the male reproductive development. Zebrafish models
have shown a multitude of effects in both females and males including impairment in the
release of reproductive hormones, head and body morphology, decreases in spawning,
and dysfunction in gene expression associated with behavior and development [24–26].
Although there is much known about the effects of atrazine as a reproductive toxicant
and endocrine-disrupting chemical in regard to the hypothalamus, specifically the HPG
axis, the exact mechanism (or mechanisms) of toxicity have yet to be elucidated. Studies
are beginning to explore the hypothalamic-pituitary-adrenal (HPA) axis as well as the
central nervous system’s role with neurotransmitters and how these adverse outcomes
are connected through crosstalk between systems in the brain [27–32]. The research on
atrazine as a neurotoxicant is limited at this time and has been waived for consideration in
human health risks assessments by the US EPA. However, the studies that are available
regarding adverse effects on neurotransmission suggest that atrazine neurotoxicity is worth
exploring, because of the potential for abnormal neurotransmitter release and dysfunction
to cause neuropsychiatric and neurodegenerative diseases [33].
The hypothalamus is an important region of the brain that plays a major role in the neuroendocrine system and is of particular interest in regard to atrazine exposure [7–9,27,28,30,34].
The hypothalamus is responsible for the production and release of seven neurohormones,
including GnRH, corticotropin-releasing hormone (CRH), and dopamine [35]. These neurohormones are produced by neuroendocrine neurons that are prevalent in two regions of the
hypothalamus, but more specifically, form the paraventricular hypothalamic nucleus (PVH),
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2. Role of Major Neuroendocrine Hormones Regulated by the Hypothalamic-Pituitary Axes
The harmonious interaction of the hypothalamus in the CNS as well as multiple
glands in the endocrine system gives rise to the study of the complex system known
as the neuroendocrine system. The hormones involved in the neuroendocrine system
are specifically associated with different hypothalamic axes [37]. The functions of these
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hormones are discussed in detail to provide an understanding of their importance when
referenced in regard to atrazine exposure.
2.1. Hypothalamic-Pituitary-Gonadal Axis
2.1.1. Gonadotropin-Releasing Hormone (GnRH)
GnRH is a critical neurohormone released by the hypothalamus in the regulation of
reproductive function. Release of GnRH from the hypothalamus into the portal circulation
allows it to reach the anterior pituitary. GnRH is released in a pulsatile mode, where there
are specific events in which it is released, as well as a surge mode, where there is a constant
concentration of GnRH prior to ovulation in females [38,39]. Once GnRH reaches the
anterior pituitary, the secretion of gonadotropins LH and FSH are triggered. In the event
that the normal pulsatile release of GnRH is disrupted and constant surges occur when
not appropriate, the GnRH receptors can become desensitized and inactive in the anterior
pituitary, causing a direct impact on the secretion of LH and FSH [38].
2.1.2. Luteinizing Hormone (LH)
LH, as mentioned, is released by the anterior pituitary following stimulation by
GnRH [40]. Typically, low pulse frequencies of GnRH are associated with the synthesis and
release of LH [41]. LH is an important neurohormone during development because of its
contribution to the evolution of immature germ cells into mature cells for both males and
females. There are other roles of LH that do differ between sexes. In males, LH prompts the
production of testosterone in Leydig cells, while in females LH is responsible for prompting
the synthesis of steroid hormones such as estrogen and progesterone. Testosterone, estrogen, and progesterone then also negatively feedback to control the concentration of LH
that is secreted creating a loop. These pathways are important in a mature organism and
also in the developing organism. Stability of these pathways during developmental stages
is key, because LH is important in the reproductive development of an organism [40].
2.1.3. Follicle-Stimulating Hormone (FSH)
FSH, along with LH, is released after stimulation of the anterior pituitary by GnRH
from the hypothalamus. As previously mentioned, high pulse frequencies of GnRH from
the hypothalamus are associated with the synthesis and secretion of LH and in contrast, low
pulse frequencies are typically associated with the synthesis and secretion of FSH. FSH in
developing males is responsible for the increase in production of Sertoli cells, which amount
to a large portion of the testes. Proliferation of the Sertoli cells is important, because they
produce a hormone that prevents female genitalia from forming inside the organism. In female
development, FSH aids in the development of the ovarian follicles. In mature organisms, FSH
plays a slightly different role. In the mature female, FSH triggers aromatase synthesis in the
ovaries, which is useful in the modification of androgens to estradiol. In mature males, FSH
regulates the production and function of sperm in conjunction with testosterone [41].
2.2. Hypothalamic-Pituitary-Adrenal Axis
2.2.1. Corticotropin-Releasing Hormone (CRH)
CRH is the main neurohormone that regulates the HPA axis through its response to
stressors. When stress is experienced, the hypothalamus is triggered to synthesize and secrete
CRH, which travels to the anterior pituitary to signal for the synthesis and release of ACTH.
CRH also activates the expression of proopiomelanocortin (POMC). Aside from triggering the
release of ACTH, the CRH plays a role in the immune system as well, being activated by not
only stress, but also cytokines [42]. CRH provides linkage of the HPA axis across systems.
2.2.2. Adrenocorticotropic Hormone (ACTH)
ACTH is controlled by the hypothalamus through the secretion of CRH after exposure
to stressors, as previously mentioned. ACTH’s assigned destination organ is the adrenal
cortex where it triggers the secretion of glucocorticoids and androgens. The glucocorticoids
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then help regulate both ACTH and CRH through a negative feedback loop to mediate the
response to stress [43].
3. Effects of Atrazine on Major Neuroendocrine Hormones
Atrazine is known to be an endocrine-disrupting chemical having effects on the
signaling pathways of the neuroendocrine system previously discussed. The system of
importance when reviewing adverse health outcomes is typically the reproductive system
since many of the neuroendocrine hormones affected play a role in different aspects of
reproduction. There can be difficulty in defining mechanisms of atrazine as an endocrinedisrupting chemical, because there are many factors that play a role in the adverse outcomes
that are observed including when the exposure occurs, the length of the exposure, as well
as the dose or concentration of the exposure. Many different models have been used to
explore the effects of atrazine exposure including various cellular systems, rodents, and
zebrafish. There have also been multiple different time points studied, because atrazine has
effects on the development of organisms as well as effects on mature adult organisms [7].
3.1. HPG Axis
The hypothalamus is of particular importance when studying atrazine due to the
neuroendocrine outcomes that are continuously proven in the literature [7–9,27,28,30]
(Table 1). The hypothalamus is abundant in GnRH neurons that produce and release the
neurohormone GnRH [9,35]. A study done on the exposure of atrazine at 200 mg/kg in
female rats revealed that GnRH release is inhibited following exposure to atrazine, directly
affecting the synthesis of LH and FSH [7,8]. Downstream, the dysregulation of these
gonadotropins can impact the secretion of sex hormones [44]. This study also suggested
that the secretory aspect of GnRH was affected independently of protein expression and
mRNA levels, so there is likely an upstream target of the GnRH neurons that atrazine is
targeting [8]. An additional study with female Wistar rats confirmed the adverse effects
that were likely to be seen on the LH surge, because of the known outcomes of atrazine on
GnRH. An atrazine exposure of 4 days at 50, 100, or 200 mg/kg caused a decrease in the LH
surge, but after withdrawal of exposure, levels of GnRH and LH were stabilized to normal
levels [9]. Although levels of these important neuroendocrine hormones have the potential
to regulate themselves after an exposure has commenced, small windows of exposure
like the one tested in the mentioned study, can have the potential to cause pathology and
dysfunction if occurring at a critical time during development. Other studies looking
at ovariectomized female rats found that the LH surge was decreased after a series of
exposures to atrazine. A single exposure at the lower doses of 10, 30, or 100 mg/kg showed
an increase in the LH surge as well as an increase in Kiss1 expression in the anteroventral
periventricular nucleus (AVPV) following a 1 h exposure, suggesting that atrazine also
plays a role in changing the surge [45]. The Kiss1 gene is responsible for regulating GnRH
and in a similar study in the same strain of rats, Kiss1 was inhibited by a series of atrazine
exposures at 100 mg/kg in the AVPV [46]. A decrease in LH levels following atrazine
exposure was also witnessed in male rats exposed to atrazine between 1 and 200 mg/kg
and was suggested to be the cause of the decrease in testosterone in the same study [47].
Seeing changes in LH across both male and female rat models supports the hypothesis that
the hypothalamus is the target of atrazine causing many downstream effects. Furthermore,
studies have also shown decreases in FSH in male rats and female rats exposed to 100, 200,
or 400 mg/kg atrazine. This finding is expected based on the relationship of FSH to GnRH
with studies in zebrafish confirming a decrease in GnRH after an embryonic exposure
to 0.3, 3, or 30 ppb (µg/L) atrazine via immersion [26,48]. Overall, the cumulative body
of research in this area confirms a wide range of atrazine exposure doses over short and
longer term durations attenuates LH surge and disrupts estrous cyclicity. Based on these
observations the US EPA anchored the dietary chronic exposure to the attenuation of the
LH surge with a NOAEL at 1.8 mg/kg/day and the LOAEL at 3.65 mg/kg/day. These
studies focused on the reproductive outcomes are reviewed in more detail in [7].
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Table 1. Atrazine adverse impacts reported along the HPG axis.
Reference

Species

Atrazine
Exposure a

Length of Exposure

Results

Foradori et al. [8]

Ovariectomized Adult Female
Wistar Rats

200 mg/kg

4 days, gavage

Reduction in GnRH pulse frequency at
200 mg/kg

4 days, gavage

Reduction in LH and FSH surges at all
concentrations and at 200 mg/kg, respectively
due to decrease in GnRH neurons in
100 mg/kg and 200 mg/kg concentrations,
4 days after treatment GnRH neuronal function
returned to normal

Foradori et al. [9]

Ovariectomized Adult Female
Wistar Rats

Goldman et al. [45]

Ovariectomized, Estrogen-Primed
Long Evans Hooded Female Rats

10, 30, or 100 mg/kg

4 days or single administration

Suppressed LH surge after four daily
treatments at 100 mg/kg, elevations in LH
surge after single administration of 10, 30, and
100 mg/kg

Kimura et al. [46]

Ovariectomized Female Wistar
Rats

100 mg/kg

5 days, orally

Reduced LH surge and Kiss1 mRNA expression
in AVPV

Trentacoste et al. [47]

Peripubertal Male Sprague
Dawley Rats

1–200 mg/kg

Day 22–47, gavage

100 and 200 mg/kg reduced serum and
intratesticular testosterone, reduced serum LH

Wirbisky et al. [26]

Zebrafish

0.3, 3, or 30 ppb (µg/L)

1–72 hpf

Increase in progesterone at 3 and 30 ppb,
increase in follicular atresia

Mokhtari et al. [48]

Male Wistar Rats

100, 200, or 400 mg/kg

14 days intraperitoneally

Serum LH decreased in 200 and 400 mg/kg
group, FSH decreased in 400 mg/kg group,
decrease in testosterone in experimental groups

a

50, 100, or 200 mg/kg

NOAEL is 10 mg/kg/day and LOAEL is 70 mg/kg/day for acute dietary exposure in females aged 13–50 years.
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3.2. HPA Axis
Although the focus of atrazine toxicity is typically on the HPG axis, a few studies have
now also shown that the HPA axis function is affected by atrazine exposure as well. Brain
transcriptomic data of adult male zebrafish exposed to 0.3, 3, or 30 ppb atrazine only during
embryogenesis revealed that the HPA axis may also be affected [26]. In addition, a study
in female rats discovered that atrazine exposure of 75 mg/kg caused an increase in the
pituitary hormone ACTH [28]. A more recent study explored the CRH receptors as toxicity
targets and found that exposure to atrazine or the chlorometabolites, desethylatrazine
(DEA) and deisopropylatrazine (DIA), at 100 mg/kg caused an increased release of CRH
into the vasculature, which was responsible for the increase in ACTH [27]. The HPA axis
is responsible for responding to stressors and triggers the synthesis and release of these
hormones [30]. Overall, there is limited research available on the HPA axis and atrazine
in general, but one study did provide evidence that exposure in adult male rats showed
an increase in ACTH at a LOEL of 12.5 mg/kg atrazine and at 135 mg/kg diamino-schlorotriazine (DACT), a major metabolite of atrazine [49]. Another study found proteomic
changes of adrenal proteins and testis proteins that correlate to testosterone found in serum
in both intact and castrated male rats after exposure to atrazine, further supporting the
HPA axis as a target of atrazine toxicity [50], but additional research is needed to further
the understanding of atrazine’s potential impacts along this axis.
4. Role of Major Neurotransmitters in the Hypothalamus
Neurotransmitters are important signaling molecules of the CNS that are produced
by specific neurons located in particular parts of the brain. In regard to brain function,
neurotransmitters are an essential aspect of the system, helping regulate basic bodily
functions, maintaining homeostasis, response to stress, motor functions, emotions, and
more. Each neurotransmitter is responsible for relaying information between neurons so
the brain and other parts of the body can respond accordingly to different events the body
is experiencing. The CNS is also an adaptive system having the capability of forming
memory to be able to respond more adequately to similar scenarios in the future [51].
The hypothalamus is a unique part of the brain playing a role in the endocrine
system as previously discussed, but also in the CNS. Some neurons are located within
the hypothalamus, while other neurons have projections into this brain region. These
neurons are involved in the production and release of key neurotransmitters that signal
the hypothalamus to carry out its functions. Temperature regulation, autonomic nervous
system regulation, as well as appetite control are some of the bodily functions that the
hypothalamus regulates that are non-endocrine functions. The disruption of these key
neurotransmitters in signaling and sending information to the hypothalamus not only
disrupts its role in neuroendocrine functions, but also in other homeostatic functions and
has the potential to lead to different pathologies [52].
4.1. Dopamine
Dopamine is an important neurotransmitter that balances certain processes of the
CNS including learning, memory, motor activity, and motivational behaviors in the adult
brain [53]. The pathways needed for the mentioned behaviors and movement are impacted
by dopamine during development as well. Dysregulation in dopamine and signaling
can affect neurocircuitry by altering certain neurons [54]. The substantia nigra, ventral
tegmental area (VTA), and the hypothalamus are the three main areas of the brain where
dopamine is produced and released to the striatum, nucleus accumbens, and the pituitary,
respectively [55,56] (Figure 2). This release occurs through the dopaminergic pathways
known as the nigrostriatal pathway, mesolimbic pathway, mesocortical pathway, and
the tuberoinfundibular pathway [35,57]. Dopamine synthesized in the hypothalamus
by the tuberoinfundibular (TIDA) neurons is of particular importance in the neuroendocrine system. Dopamine is typically considered a neurotransmitter, but in regard to the
tuberoinfundibular pathway, originating in the hypothalamus, dopamine is considered a
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neurohormone, because of its release into the pituitary portal system to inhibit the secretion of a pituitary hormone, prolactin [35]. The TIDA neurons controlling hypothalamic
dopamine synthesis and release are found in a very specific region of the hypothalamus
known as the arcuate nucleus, whose main function is to regulate homeostasis and pathways that control food intake, energy usage, and body weight [58]. The importance of
knowing the role of the arcuate nucleus in relationship to both dopamine and atrazine
exposure will be further discussed below. In addition, dopamine in the hypothalamus also
Toxics 2021, 9, x FOR PEER REVIEW
8 of 24
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Serotonin also has an active role in the activation of the HPA axis in the release of
CRH, which further controls the release of ACTH [64]. Activated serotonin receptors in
the brain cause an increase in CRH into the anterior pituitary resulting in an increase in
the secretion of ACTH [65]. ACTH secretion then influences the release of glucocorticoids
and androgens from the adrenal cortex. Cortisol is responsible for both the negative feed-
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Serotonin also has an active role in the activation of the HPA axis in the release of
CRH, which further controls the release of ACTH [64]. Activated serotonin receptors in the
brain cause an increase in CRH into the anterior pituitary resulting in an increase in the
secretion of ACTH [65]. ACTH secretion then influences the release of glucocorticoids and
androgens from the adrenal cortex. Cortisol is responsible for both the negative feedback
loop to regulate CRH levels as well as assisting in the regulation of glucose metabolism
and immune function [43]. The role of serotonin in the hypothalamus is important, because
of its upstream position in many pathways, especially in this brain region.
4.3. Norepinephrine
Norepinephrine is a neurotransmitter that is primarily produced in the locus coeruleus
of the brain stem and plays a role in the regulation of attention, arousal, and other cognitive
behaviors. It is released from the neurons in this small brain region in response to stressful
situations to many other brain regions through vast neuronal projections [66]. A stepwise
synthesis occurs to produce the neurotransmitter starting with the amino acid tyrosine to
synthesize dopamine. Dopamine-β-hydroxylase is then used to synthesize norepinephrine
from dopamine [67]. The locus coeruleus and norepinephrine have a noticeable role in
waking and arousal and when activated, even moderately, is not compatible with sleep
state. Increased activity of the locus coeruleus is suggested to contribute to stress-related
disorders [68]. The locus coeruleus is also known to have strong ties to the hypothalamus
through the paraventricular nucleus, which is conceivably the main area of the brain that
processes stressful stimuli experienced by the body. The axis between the locus coeruleus
and the hypothalamus connects the autonomic nervous system with the CNS and the
neuroendocrine system [69]. The links between the locus coeruleus, the hypothalamus,
and the other systems listed suggest that dysregulation of norepinephrine or the systems in
which it is involved can potentially have major adverse effects on the body. Norepinephrine
is also a key regulator of the HPA axis and is an excitatory molecule that allows for secretion
of CRH as well as ACTH dose-dependently [70,71]. Norepinephrine, in conjunction
with dopamine, is also responsible for the inhibition of prolactin release and suppresses
secretion dose-dependently [72]. Similar to dopamine, norepinephrine is involved in an
array of different pathways, making it an important neurotransmitter to study in regard to
environmental exposures that are known to affect the hypothalamus in particular.
4.4. Gamma-Aminobutyric Acid
Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter in the mature
brain, with neurons producing it in multiple areas of the brain, including the hypothalamus.
GABA is synthesized from glutamate and function together as the antithesis of each other
in the mature brain, where glutamate is the excitatory neurotransmitter [73]. GABA has
an important role in the developing brain in processes involved in neurogenesis and
also has the opposite function during this time period, being excitatory like glutamate
rather than inhibitory [74]. In relationship to the hypothalamus’ function and pathways,
GABA has been studied and shown to have relationship in regulation of ACTH, prolactin,
gonadotropins, growth hormone, CRH, and a few others that are outside the scope of
this review [75,76].
4.5. Glutamate
Glutamate, as mentioned previously, is the opposite of GABA in the mature brain and
acts as an excitatory neurotransmitter. The body is very sensitive to the concentrations, location, and timing of secretion of this neurotransmitter to regulate excitatory signals, because
of its role in multiple metabolic pathways [77]. The relationship between the hypothalamus
and this excitatory neurotransmitter has been investigated and glutamate was discovered
to be the primary excitatory agent that is released from the hypothalamic neurons. Since
the hypothalamus is a regulator of the autonomic nervous system, neuroendocrine system,
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as well as multiple homeostatic functions, the role of glutamate in the hypothalamus is of
extreme importance [78].
4.6. Acetylcholine
Acetylcholine is a very important neurotransmitter but in regard to the CNS, little is
known. What has been discovered is that acetylcholine is released from the basal forebrain
and the mesopontine tegmentum area and is mostly involved with memory, motivation,
arousal, and attention [79]. Acetylcholine is distributed to the hypothalamus and has been
investigated and thought to be the excitatory neurotransmitter of this area of the brain in
absence of glutamate when the glutamate/GABA interactions are imbalanced [80]. This
important finding suggests that acetylcholine takes over the responsibility that glutamate
has in regulating all of the homeostatic functions of the hypothalamus when needed.
5. Effects of Atrazine on Major Neurotransmitters
As mentioned, atrazine is well known for being an endocrine-disrupting chemical,
impacting the reproductive system due to alterations in release of hormones in that system. While this is an important area of study, there is also now research indicating that
atrazine can impact neurotransmitters. These neurotransmitter alterations can also result
in many downstream effects in the pathways in which they are involved, including some
neuroendocrine pathways where neurotransmitter signaling is needed. Some of the key
neurotransmitters have shown adverse effects in their concentrations or their signaling
after different atrazine exposure scenarios in cellular models, rodents, and the zebrafish.
Currently, most of the focus on atrazine’s impacts on neurotransmitters has been in other
areas of the brain outside of the hypothalamus since generally the hypothalamus is known
more for being a neuroendocrine structure. As such, neurotoxicity outcomes have been
waived in recent human health risks assessments by the US EPA. Regardless, the effects
that atrazine has on these neurotransmitters in other areas of the brain can play a role in
the hypothalamic function and other pathways in which the hypothalamus is involved,
warranting further research to define exposure limits for the neurotoxic outcomes.
5.1. Dopamine
Atrazine’s impacts on dopaminergic pathways in other brain regions beyond the hypothalamus are extensively studied. Although the hypothalamus is one of the main areas
where dopamine is produced, research on dopamine dysfunction, including changes in
concentration, is focused on the parts of the brain involved in the behaviors and processes
listed previously. Therefore, there is a gap in the literature when it comes to atrazine exposure and the effects on the tuberoinfundibular pathway and dopamine that is produced and
synthesized in the hypothalamus. However, there have been cell model studies conducted
that can provide insight into the general effects on dopamine (and norepinephrine) in the
brain that suggests that those outcomes are applicable to the hypothalamus specifically
(Table 2). A study conducted with PC12 cells investigated the metabolism of dopamine
after atrazine exposure and measured both intracellular dopamine concentrations as well
as norepinephrine. It was discovered that exposure to atrazine, at concentrations ranging
from 0 to 200 µM, altered the ability of the cells to synthesize these catecholamines with a
decrease in both dopamine and norepinephrine intracellularly in a concentration dependent
manner [81]. Atrazine’s adverse effect on dopamine in the hypothalamus specifically can
also be supported by another study that concluded that the hypothalamus is a reasonable
target of atrazine, because of the adverse effects that atrazine exposure had on secretion of
prolactin, which is regulated by hypothalamic dopamine [82]. Decreased dopamine in the
hypothalamus not only affects the release of prolactin, but also the negative feedback loop
of this cycle as well where prolactin promotes secretion of dopamine [59]. It is important
for hypothalamic dopamine to be studied more closely in regard to atrazine exposure,
because of its importance in pathways associated with the neuroendocrine system.
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As mentioned, there are many studies that look at areas of the brain other than the
hypothalamus where dopamine is synthesized and those corresponding pathways after atrazine exposure. For example, multiple studies have been conducted on striatal
dopamine [31,83]. There are also other brain regions that experience dopamine dysregulation that are more closely connected to the adverse outcomes of the hypothalamus
that explain some of the behavior that is seen following atrazine exposure. For instance,
dopamine levels in the hippocampus, which serves as a connection in the mesolimbic pathway to transport dopamine from the VTA to the nucleus accumbens, were examined [55].
In this study, rats were exposed to atrazine during developmental stages and impacts on
hippocampal dopamine levels as well as mRNA and expression levels of D1 dopamine
receptor were determined. Here, it was reported that in the low dose atrazine-exposed
group of 10 mg/kg body weight (current acute dietary NOAEL), dopamine levels were increased in the hippocampus compared to the control and the high dose group of 100 mg/kg
body weight, while D1 dopamine receptor expression and mRNA levels responded in a
decreasing dose-dependent manner [53]. The increase in dopamine at the low dose was attributed to the compensatory action of the dopaminergic neurons to the atrazine exposure,
because the decrease in dopamine in the higher concentration exposure was comparable
to a previous study [31]. Further studies confirming lower concentrations of dopamine
after exposure to atrazine up to 100 mg/kg have also looked at the association of reduced
gene expression of Nurr1 and VMAT2 in pubertal rats as well as juvenile rats exposed
in utero, which are both associated with dopaminergic pathways [84–86]. In addition, it
was observed that a developmental atrazine exposure at 10 or 100 mg/kg in male Sprague
Dawley rats led to hippocampal lesions and suggests that MEK/ERK/CREB cycles may
play a role in the effects seen [87]. Furthermore, striatal dopaminergic pathways were also
identified to be responsible for inducing apoptosis and autophagy amongst dopaminergic
neurons, potentially causing these changes in dopamine concentration that were reported
in the previously mentioned studies [88]. Rat striatal slices exposed to atrazine from adult
male Sprague Dawley rats provided evidence that the decreases in dopamine are most
likely due to atrazine affecting the storage or cellular uptake of the neurotransmitter [89,90].
This hypothesis was further confirmed by a study looking at the striatal vesicles, which
saw an increase in cytosolic dopamine, suggesting issues regarding neurodegenerative
pathologies [91]. Cell models are also providing evidence that atrazine exposure between 1
and 250 µM can cause phenotypic changes that are associated with Parkinson’s Disease.
As such, it is important to continue to study the effects that atrazine has on the brain and
the CNS, because other neurodegenerative diseases may also be of concern [91].
Numerous studies have been conducted completely independent of the hypothalamus that show dysfunction in the dopaminergic pathway of the striatum leading to
a variety of adverse effects. Chronic exposure to atrazine at 10 mg/kg is reported to
affect locomotor activity, impair motor coordination, and impair learning tasks, but did
not affect concentration of dopamine in the hypothalamus in the male Sprague Dawley
rat [92]. These outcomes are supported by another study in the same rodent model that
found that repeated atrazine exposure at 100 mg/kg caused a decrease in dopamine as
well as locomotor activity [93]. This study also reported that after function returned to
normal following exposure, an amphetamine challenge caused drastic stimulation of the
dopaminergic system, suggesting the reasoning for certain behavior outcomes observed
after atrazine exposure [93]. Non-dopaminergic neurons were also studied and were associated with a decrease in locomotor activity at a dose of 100 mg/kg, supporting the fact
that atrazine causes a general hypoactive effect even after acute exposures [94]. Furthermore, subtoxic, environmentally relevant doses of atrazine, at 1 and 100 µg/kg (0.001 and
0.1 mg/kg), were administered perinatally to CD1 mice and resulted in subtle functional
and behavioral changes [95]. These behavior outcomes seen at different time points in
development provide insight into the many effects that atrazine can have based on timing
of exposure.
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Table 2. Reported adverse effects on dopaminergic systems following atrazine exposure.
Reference

Species

Atrazine Exposure a

Length of Exposure

Results

Das et al., 2000 [81]

PC12 Cells

12.5, 25, 50, 100, or 200 µM

6, 12, 8, 24, 48 h

Decrease in intracellular DA,
concentration dependent outcomes,
NE reduction at 100 and 200 µM

Coban and Filipov, 2007 [31]

Male Juvenile C57BL/6 Mice

5, 25, 125, or 250 mg/kg

14 days, gavage

Dose-dependent decrease of DA in
striatum up to one week after
exposure

0.1 or 10 mg/kg

Dams treated Gestational Day 1Postnatal Day 21, Male offspring
continued 6 months upon weening

Male offspring showed decrease in
DA and DOPAC levels at low and
high concentrations, 10 mg/kg
showed disruptions in motor
function
DA levels increased in
hippocampus in low dose group,
D1DR expression levels decreased
in dose-dependent manner

Walters et al., 2015 [83]

Male Sprague-Dawley Rats

Li et al., 2018 [53]

Sprague Dawley Rats

10 or 100 mg/kg

30 consecutive days starting at
Postnatal Day 28, gavage

Li et al., 2015 [84]

Pubertal Male Sprague Dawley Rats

50, 100, or 200 mg/kg

28 days, gavage, postnatal day
27–54

Exposure to higher doses led to
decreased levels of DA and
decreased expression of Nurr1

Sun et al., 2014 [85]

Sprague Dawley Rats

Pregnant Dams received 10 µL/g
body weight or vehicle, offspring
received 0, 25, or 50 mg/kg/day

Pregnant dams starting GD 5,
offspring until PND 22, gavage

Ventral midbrains examined and
found DA concentrations and
mRNA of Nurr1 decreases in
offspring at both concentrations

Li et al., 2014 [86]

Sprague Dawley Rats

25 or 50 mg/kg/day

Pregnant dams received ATR from
GD 0, and offspring received ATR
until PND 1

6 months after treatment DA and
expression of Nurr1 were decreased
in striatum and substantia nigra

30 days, starting at PND 35

Impairment of memory after
exposure, downregulation of
protein and mRNA expression
levels associated with
MEK/ERK/CREB pathway at low
and high concentrations

Li et al., 2019 [87]

Male Sprague Dawley Rats

10 or 100 mg/kg
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Table 2. Cont.
Reference

Song et al., 2015 [88]

Species

Male Wistar Rats

Atrazine Exposure a

10, 50, or 100 mg/kg

Length of Exposure

Results

3 months, gavage

Nigrostriatal dopaminergic system
pathways examined and found
micromorphology suggesting
neuronal apoptosis and
mitochondrial autophagy of DA
neurons at all concentrations,
increasing in severity with
increasing dose

Filipov et al., 2007 [89]

Adult Male Sprague Dawley Rats

up to 500 µM

Striatal slices incubated for 4 h

Tissue DA levels decreased
dose-dependent at 100 µM or
greater, exposure interferes with the
uptake and storage of DA

Hossain and Filipov, 2008 [90]

Striatal synaptosomes and vesicles
from Adult Male Sprague Dawley
Rats

1–250 µM

15 min

Atrazine and two metabolites
caused inhibition of DA uptake
dose-dependently

Bardullas et al., 2011 [92]

Male Sprague Dawley Rat

10 mg/kg

1 year

Impaired motor coordination,
greater spontaneous locomotor
activity, decrease in striatal DA

Rodríguez et al., 2013 [93]

Adult Male Sprague Dawley Rat

100 mg/kg

6 IP injections over 2 weeks

Hypoactivity following injection
that lasted for 5 days, reductions in
striatal DA, amphetamine 2 months
post exposure caused significant
stimulation

Rodriguez et al., 2017 [94]

Male Sprague Dawley Rats

100 mg/kg

Single injection

Significant decrease in locomotor
activity, cells other than DA neurons
cause locomotor dysfunction

0.001 or 0.1 mg/kg

Dams exposed GD 14 through
PND 21

Feminization of behavioral profile in
male offspring, learning
performance alterations in adults at
both concentrations

Belloni et al., 2011 [95]
a

Juvenile and Adult CD1 Mice

NOAEL is 10 mg/kg/day and LOAEL is 70 mg/kg/day for acute dietary exposure in females aged 13–50 years. Residential NOAEL is 6.25 mg/kg/day and LOAEL is 12.5 mg/kg/day, which accounts for
infants and children. For chronic dietary exposure for all ages, NOAEL is 1.8 mg/kg/day and LOAEL is 3.65 mg/kg/day based on 6-month rat study.

Toxics 2021, 9, 207

14 of 24

5.2. Serotonin
Impacts on serotonin following atrazine exposure have not been extensively investigated, but some studies report dysregulation. Alterations in the serotonergic system and
associated pathway genes were reported in adult female zebrafish following an embryonic
atrazine exposure at 0.3, 3, or 30 ppb (µg/L) [96]. Further, in juvenile and adult offspring of
C57BL/6 mice exposed at an estimated 1.4 mg/kg/day, which is below the current chronic
dietary NOAEL, showed a significant decrease in serotonin of the perirhinal cortex in only
female adult offspring and was linked to a deficiency in memory. This conclusion was
confirmed in the novel object recognition test [97]. In zebrafish, it was also observed that
paternal atrazine exposure at 0.3, 3, or 30 ppb had intergenerational dysfunction of the
serotonergic system in the offspring [98]. Although only a few limited studies have been
completed, each gives support that atrazine may interfere with the serotonergic system
with potential for sex-specific responses at doses near or below the current chronic dietary
NOAEL at 1.8 mg/kg/day.
5.3. Gaba and Glutamate
Similar to serotonin, there have not been many studies on the effects of atrazine
exposure on GABA or glutamate. Typically, these two neurotransmitters are studied
together, because they act in concert in the brain and one is a precursor to the other. One
study in male albino rats did conclude that there were increases in glutamate and GABA in
several areas of the brain, but not specifically in the hypothalamus after atrazine exposure at
1 or 10 mg/kg [99]. This study suggests that there may be alterations of these concentrations
in other areas of the brain as well, such as the hypothalamus, and at different points during
development where GABA plays a different role. Conversely, in zebrafish no significant
changes in GABA were observed in the brain of adult males or females that were exposed
to 0.3, 3, or 30 ppb atrazine during embryogenesis [96]. It is difficult to conclude at this
time the relationship between atrazine exposure and GABA/glutamate given the limited
studies, but similar to other neurotransmitter systems further investigation is needed to
determine potential impacts in the different brain regions.
5.4. Acetylcholine
Acetylcholine is also a neurotransmitter that has not been extensively studied with
atrazine exposure. There has been one study that utilized the zebrafish model to examine
acetylcholinesterase activity in the brain following atrazine exposure. Here, both acetylcholinesterase (AchE) activity in muscles and in the brain were investigated, but alterations
were only detected in the brain. The reduction in AchE in the brain and the behavior
outcomes that were also observed in this study after atrazine exposures of 10 or 1000 µg/L
provide proof that atrazine may affect defensive behaviors in the zebrafish, which can be
associated with an issue in neurotransmission of acetylcholine, described by the reduction
in the AchE activity [100]. Overall, more studies are needed to further understand the
influence of atrazine on this neurotransmitter.
6. Relevance to Human Exposure
A clear indication of human atrazine exposure is complicated by limitations in accurate drinking water monitoring data and confines in biomonitoring assessments. These
drawbacks present difficulty when working to translate doses and concentrations used
in laboratory studies of relevance to human health. According to the United States Centers for Disease Control and Prevention (US CDC), it is unknown whether the atrazine
concentrations that are detected in the environment, and the levels that are observed via
biomonitoring, result in adverse human health effects. The US CDC also acknowledges that
particular attention needs to be paid to seasonal concentrations of atrazine in the drinking
water sources of communities in regions where atrazine is applied on agricultural fields,
where these atrazine concentrations can be higher than the limits set by the US EPA (i.e.,
greater than 3 ppb in drinking water) [101]. This is an important factor when discussing
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exposure assessments since atrazine concentrations can vary depending on time of year
and this is not always noted in these studies. It should also be recognized that individuals
residing in rural communities in regions where atrazine is applied are likely to rely on
private drinking water wells, which are not routinely monitored for chemical contaminants.
Furthermore, while the US CDC claims that the general population is not as frequently
exposed to atrazine through their drinking water, a study evaluating urinary profiles to
test for atrazine metabolites demonstrated drastically different metabolite profiles, suggesting that multiple metabolites need to be assessed to reflect atrazine exposure, rather
than single evaluation of the parent compound and/or of one main metabolite [101,102].
Barr et al. reported that the percent distribution of atrazine metabolites in human urine
varies with the extent of exposure (i.e., high or low acute exposures or environmental
exposures) [103]. Specifically, the environmental exposures resulted in a distribution of
77% diaminochlorotriazine (DACT), 15% desethylatrazine (DEA), 6% deisopropylatrazine
(DIA), and 2% atrazine mercapturate [103]. This is another important point to consider
as the US CDC biomonitoring information available suggests that recent exposure assessments are only measuring the urinary levels of atrazine mercapturate [101]. Atrazine
mercapturate was detected at the lowest percent compared to the other major metabolites
and thus, is very likely not accurately representing atrazine body burden and exposures in
the US population.
In the environment, atrazine’s half-life is different in both soil and water systems and
can vary depending on pH, exposure to sunlight, oxygen level, as well as climate conditions.
In soil, the half-life of atrazine is between 60 and 75 days, while in water with direct sunlight
it is 168 days. Atrazine’s great potential for reaching both ground and surface water is a
major cause for concern and has prompted epidemiological studies to investigate if there
are differences among populations in communities where atrazine use is more prevalent
as opposed to areas with less atrazine use [103]. Overall, to understand atrazine exposure
risks in humans, it is important to consider atrazine’s chemical properties in a variety of
environmental conditions, which will reflect likelihood of atrazine contaminating drinking
water sources and thus, lead to environmental human exposures. In addition, consideration
of the time of year of exposure assessments informs on higher risks of exposure to atrazine
at elevated concentrations in drinking water sources, since concentrations are known to
spike in drinking water sources following the first major rain event after agricultural
field application. Unfortunately, it was discovered that many community drinking water
systems in the Midwestern US aware of this seasonal fluctuation were strategically testing
atrazine during certain months to avoid identification of the chemical spike to alleviate
economic burden associated with removing atrazine from the drinking water. This atrazine
water testing strategy met the previous US EPA drinking water testing requirements, but
the spikes in atrazine concentrations in drinking water sources and subsequently the risk
of human exposure to higher atrazine concentrations were still occurring. This concern
was recognized when the former owner of atrazine, Syngenta (ChemChina purchased
Syngenta in 2017), was required to fund additional atrazine water monitoring during
higher risk months for a more informed record of atrazine concentrations in drinking
water during these time periods. This increased water monitoring also gave a more
accurate understanding on when and if actions were needed to remove atrazine from
community drinking water sources, when the chemical was detected at concentrations
above the US EPA MCL and ultimately decrease risk of human exposure. In contrast, in
2020 the US EPA relaxed these regulations allowing for 50% more atrazine to enter water
bodies and suspended the requirement for this more frequent water testing. As such,
increased atrazine concentrations in drinking water sources are again likely and present
higher risks of environmental atrazine exposure. In summation, it can be concluded that
multiple limitations are present in our current knowledge for accurate estimates of risks of
environmental atrazine exposure in the general population, which is further complicated
by current exposure assessments measuring only atrazine mercapturate not representing
the full atrazine body burden and exposures in humans.
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Regardless of these limitations, it is important to work to translate doses/concentrations
at which observed adverse health outcomes are observed in laboratory studies. Given
the challenges detailed in the previous paragraphs, there are questions regarding whether
the US EPA benchmark dose limit of 2.42 mg/kg per day for four days poses a risk to
human health. This value was anchored to atrazine’s effect on LH as the US EPA recognizes
atrazine’s impacts on GnRH regulation of LH release as the most sensitive endpoint for
risk assessment [103]. The health outcomes discussed above from a plethora of atrazine
studies provide evidence that there are likely many integrated pathways altered by atrazine
exposure, resulting in the multiple different health outcomes identified in these studies
including neurotoxicity, which has been waived from inclusion in the most recent atrazine
human health risk assessments [103]. As such, the argument can be made that impacts on
LH should not necessarily be the sole indicator of toxicity in regard to atrazine regulation.
There is also evidence that atrazine is persistent in soil and water dependent on
environmental conditions. In countries where atrazine use has been banned for quite
some time, this chemical is still found to be the most abundant pesticide in both soil
and groundwater, presenting continual risks for exposure [104]. Similarly, environmental
monitoring in countries where atrazine is still applied continues to detect atrazine at
concentrations above the US EPA regulatory limit of 3 ppb in drinking water sources [4].
Atrazine removal strategies may not be implemented and/or may miss chemical spikes
based on time of water testing as noted above. On the global scale, it should also be
remembered that the World Health Organization regulatory limit was revised and increased
to 100 ppb, again allowing for higher atrazine exposure concentrations in drinking water.
These combined characteristics of atrazine in the environment; testing, detection, and
removal strategies; and variations in drinking water regulatory limits globally are critical
when assessing the potential for atrazine exposure and health risks in humans.
When considering the atrazine doses/concentrations of many of the mammalian
studies discussed above, we see that many do have very similar ranges. Although the
concentrations used to dose in the in vivo studies do not align with the exact concentrations
that are found in the drinking water or soil, these concentrations must be converted into
tissue dose received in the organism. Unfortunately, a common limitation of these studies
is that they do not include the tissue dose or urinary concentrations of atrazine or atrazine
metabolites after exposure. Some of the studies, though, include exposures with the
individual atrazine metabolites including those focused on the HPA axis. Overall, these
studies conclude that the major atrazine metabolites have similar toxicity or are less
toxic than the parent chemical [27,28,49]. It does appear that mammals and fish quickly
metabolize atrazine into the major metabolites, suggesting that it may be a combination
of the parent compound and metabolites that cause many of the adverse health outcomes
observed after atrazine exposure. It is also known that the major metabolites of atrazine
are still detected in the urine of mice 48 h after administration of the dose [105]. These
toxicokinetic characteristics are important to recognize when comparing the concentrations
found in the environment and the doses used in controlled studies for a more informed
approach in translating these laboratory studies.
In addition to centering atrazine exposure concentrations to the drinking water regulatory level in toxicity tests, atrazine doses used across the different model systems are many
times determined by the no observed adverse effect level (NOAEL) and/or the lowest
observed adverse effect level (LOAEL). As noted above, the US EPA NOAEL for atrazine is
10 mg/kg/day, while the LOAEL is 70 mg/kg/day for acute dietary exposure (females
aged 13 to 50 years) based on delayed ossification of cranial bones in fetuses observed
in developmental toxicity studies in rat and rabbit [106]. These oral short-term dietary
values are slightly adjusted for residential human health risk, which considers protection of
infants and children (i.e., NOAEL is 6.25 mg/kg/day and LOAEL is 12.5 mg/kg/day). For
chronic dietary exposure, the NOAEL is 1.8 mg/kg/day and the LOAEL is 3.65 mg/kg/day
based on attenuation of the pre-ovulatory LH surge reported in a 6-month study in rats
for all [106]. Nonetheless, as mentioned above, some studies have observed neurotoxic

Toxics 2021, 9, 207

17 of 24

outcomes at doses that are lower than the NOAELs reported by the US EPA. As such, further studies are warranted that focus on neurotoxicity outcomes to determine if significant
impacts may be observed at doses lower than those based around atrazine’s impact on LH.
Atrazine is not thought to bioaccumulate, but it is not yet known where in the body
atrazine is distributed following absorption. From the above discussed studies, we do
know that atrazine exposure impacts the brain, including the neuroendocrine system and
the regions of focus in the dopaminergic studies. The overall research body to date supports
a yet to be identified neuroendocrine target of atrazine toxicity (specifically hypothalamic
target) with neuroendocrine dysfunction and neurotoxicity outcomes likely the most
susceptible systems, but other impacts such as immunotoxicity have been reported. It is
not yet well understood whether other systems or specific tissues are more susceptible. If
these limitations were addressed in future research, this would provide a more holistic
understanding of the basics of atrazine toxicity beyond the many adverse health outcomes
that are reported. We do know that there is substantial crosstalk among the endocrine and
CNS. Recognition of these integrated pathways provides support of how atrazine could
impact the multiple endocrine axes and CNS outcomes and suggests mechanisms by which
this may occur.
7. Crosstalk between CNS and Endocrine System
Crosstalk amongst different systems has been speculated between multiple physiological systems and may provide evidence as to why there are numerous adverse health
outcomes reported following atrazine exposure when the hypothalamus seems to be the
main target. The HPA and HPG axes work in concert to reduce allostatic load and if
disrupted, can have effects later in life such as anxiety, depression, and post-traumatic
stress disorder [29]. The outcomes discussed with regard to atrazine exposure and these
two hypothalamic axes provide reason to speculate that the crosstalk between these two
pathways is occurring and influencing each pathway when atrazine reaches the brain.
The hippocampus is not extensively studied in regard to atrazine exposure, but there
are a few studies that have discussed observed effects, which can help elucidate the wide
array of different outcomes, from behavior to reproduction, following atrazine exposure.
The position where the hippocampus resides in the brain allows it to be easily influenced by
the dysfunction that the surrounding brain regions experience following atrazine exposure
as well. Many studies confirm that sex hormones play a role in the developing brain
outside of the hypothalamus, which is typically associated with reproductive function. Sex
hormones that are regulated by FSH and LH are speculated to affect the development and
function of the hippocampus, which can lead to impairments in cognitive function [107].
This coincides with the previously mentioned atrazine study on the hippocampus citing
impairments to spatial memory and hippocampal D1 dopamine receptor [53]. LH and
FSH regulate the production and release of both estrogen and progesterone, which have an
abundance of receptors in the hippocampus and surrounding brain regions [44,107]. The
hippocampus’ location allows it to connect with other regions of the brain, including the
hypothalamus and striatum, which are two main regions involved in the dopaminergic
systems [55,56]. The hippocampus can therefore easily interact with regions close by, but
more importantly can also be affected by the dysfunction that these regions experience.
Dopamine receptors in the hippocampus are in abundance and play a role in anxiety
behavior [108]. This relationship was observed and confirmed in regard to atrazine exposure through behavioral endpoints analyzed in rats where anxiety-like behavior was
linked to a dysregulation in dopaminergic systems [32]. Although each part of the brain is
involved in distinct processes and have specific functions, the proximity to other areas of
the brain and the interweaving of different systems through the brain is why crosstalk is
a large factor to consider when trying to find a central target for atrazine toxicity. This is
especially true when considering neurotransmitters and the hypothalamus, because many
of the neurotransmitters have high priority functions and areas of the brain that they are
associated with, but the interactions with the hypothalamus are still relevant, especially
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One recently identified upstream target of atrazine is the kisspeptin system. Kisspeptin
is a family of hormones that are generated from the KISS1 gene that is emerging as a
potential target of atrazine due to its role in the HPG axis as well as in other parts of the brain.
This target may provide explanation as to why atrazine causes a wide array of outcomes,
from reproductive to emotional and behavioral, across different systems [109]. Kisspeptin
has been proven to alter prolactin secretion, which then affects the dopaminergic system
stemming from the hypothalamus [110,111]. The adverse outcomes in the hippocampus
after exposure to atrazine that can cause anxiety-like behavior might also be associated
with kisspeptin as a target. The literature suggests that kisspeptin expression is intertwined
with the HPA axis and its response to stressors [112]. Crosstalk that occurs between close
brain regions such as the HPA axis of the hypothalamus and the hippocampus, mentioned
previously, has the potential to induce anxiety-like behavior in the hippocampus through
kisspeptin [45,46]. These studies demonstrate how dysfunction in different neurons in the
brain can be linked to the dysfunction in the neuroendocrine system, also leading to certain
behaviors. This is the reason for speculation that the hypothalamus may be the central
target of atrazine, because many of the adverse outcomes seen can be traced back to that
area of the brain even if it is indirectly.
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Serotonin in general has not been a focus of concern in regard to atrazine exposure,
but some of the studies that are available provide evidence that gut serotonin is affected by
lower concentrations of atrazine in the male [113]. This type of dysfunction has the potential
to have an impact on the brain, specifically the arcuate nucleus in the hypothalamus, or
stem from dysfunction in the hypothalamus due to the evidence of crosstalk between the
gastrointestinal system and this area of the brain [114]. The serotonergic system and the
HPA axis also experience crosstalk based on location in the brain and dysfunction that
may occur in either or both of these systems and can lead to anxiety-like disorders [115].
These studies and the crosstalk that seems to occur between these systems is particularly
interesting because not only are the endocrine and nervous systems showing behavioral
outcomes that result from imbalances in the brain, but that other systems in the body that
are not proximal to the brain can also be affected and linked to the same region of the brain
that is of concern regarding atrazine exposure. All of the studies discussed in this review
allow for multiple hypothetical mechanisms in which atrazine toxicity occurs that seem to
be intertwined based on the evidence of crosstalk between the systems and pathways that
atrazine exposure is likely to affect.
8. Conclusions
Atrazine usage in the United States and other global regions is of public health importance not only because of the implications of atrazine as an endocrine-disrupting chemical
and reproductive toxicant, but also as a neurotoxicant and impacts on neurotransmission.
The augmentation in hormone secretion necessary for reproduction and endocrine function
that is regulated by the hypothalamic axes is prevalent in multiple animal models and
changes seen after atrazine exposure are observed in both sexes. There is reason for concern
across multiple organisms, multiple routes of exposure, multiple stages of development
when exposure occurs, and the potential of multigenerational effects. There is a wide array
of adverse health outcomes that have been discovered and studied regarding atrazine
exposure in many animal models, suggesting that there must be crosstalk within systems
in the brain and with the reproductive system, likely stemming from one single target.
Other neurotransmitters that are outside the scope of this review may also have the potential to be affected by atrazine exposure and their relationship with the current known
systems that are altered by atrazine. The effects seen based on the current research and
the complex systems that weave together a mechanistic web of dysfunction in the body
provide evidence to consider atrazine as not only of ecological concern, but of public health
concern as well. Furthermore, the current regulatory levels for human health are centered
on the NOAELs of atrazine’s attenuation of the LH surge. The US EPA identifies this
mechanism as the most sensitive and the most recent human health risk assessments have
not included neurotoxicity outcomes as these are generally investigated separate from the
neuroendocrine parameters. Recent neurotoxicity studies have identified alterations at
doses near and/or below these NOAELs, warranting further evaluation and consideration
of the intertwined neuroendocrine and central nervous systems.
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